Gene · 3822
Papers2,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,624
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FLT3L governs the development of partially overlapping hematopoietic lineages in humans and mice. | Cell | 2024 | 38701783 | PubTator, text mining | PubMed |
| NKG2C+CD57+ natural killer cells with senescent features are induced during cutaneous leishmaniasis and accumulate in patients with lesional healing impairment. | Clin Exp Immunol | 2024 | 38700066 | PubTator, text mining | PubMed |
| HIV/HBV coinfection remodels the immune landscape and natural killer cell ADCC functional responses. | Hepatology | 2024 | 38687604 | PubTator, text mining | PubMed |
| Lingering Effects of Early Institutional Rearing and Cytomegalovirus Infection on the Natural Killer Cell Repertoire of Adopted Adolescents. | Biomolecules | 2024 | 38672472 | PubTator, text mining | PubMed |
| Expression of HLA-DR and KLRG1 enhances the cytotoxic potential and cytokine secretion capacity of CD3+ T cells in tuberculosis patients. | Int Immunopharmacol | 2024 | 38652959 | PubTator, text mining | PubMed |
| Natural killer cell subsets and their functional molecules in peripheral blood of the patients with breast cancer. | Immun Inflamm Dis | 2024 | 38652012 | PubTator, text mining | PubMed |
| Decidual γδT cells of early human pregnancy produce angiogenic and immunomodulatory proteins while also possessing cytotoxic potential. | Front Immunol | 2024 | 38601161 | PubTator, text mining | PubMed |
| Long-term dynamics of natural killer cells in response to SARS-CoV-2 vaccination: Persistently enhanced activity postvaccination. | J Med Virol | 2024 | 38566585 | PubTator, text mining | PubMed |
| Adaptive NK Cells Rapidly Expand during Acute HIV Infection and Persist Despite Early Initiation of Antiretroviral Therapy. | J Immunol | 2024 | 38558245 | PubTator, text mining | PubMed |
| DELVE: feature selection for preserving biological trajectories in single-cell data. | Nat Commun | 2024 | 38553455 | PubTator, text mining | PubMed |
| The Impact of Cytomegalovirus Infection on Natural Killer and CD8+ T Cell Phenotype in Multiple Sclerosis. | Biology (Basel) | 2024 | 38534424 | PubTator, text mining | PubMed |
| Autologous T-Cell-Free Antigen Presentation System Unveils hCMV-Specific NK Cell Response. | Cells | 2024 | 38534374 | PubTator, text mining | PubMed |
| The immunopathological landscape of human pre-TCRα deficiency: From rare to common variants. | Science | 2024 | 38422122 | PubTator, text mining | PubMed |
| Integrated Analysis of Single-Cell and Bulk RNA Sequencing Data Reveals Memory-like NK Cell Subset Associated with Mycobacterium tuberculosis Latency. | Cells | 2024 | 38391906 | PubTator, text mining | PubMed |
| IL-15 reprogramming compensates for NK cell mitochondrial dysfunction in HIV-1 infection. | JCI Insight | 2024 | 38385747 | PubTator, text mining | PubMed |
| Impaired T cells and "memory-like" NK-cell reconstitution is linked to late-onset HCMV reactivation after letermovir cessation. | Blood Adv | 2024 | 38315873 | PubTator, text mining | PubMed |
| Association of HBsAg levels with differential gene expression in NK, CD8 T, and memory B cells in treated patients with chronic HBV. | JHEP Rep | 2024 | 38314025 | PubTator, text mining | PubMed |
| γδ T cells mediate robust anti-HIV functions during antiretroviral therapy regardless of immune checkpoint expression. | Clin Transl Immunology | 2024 | 38299190 | PubTator, text mining | PubMed |
| Crosstalk Between NK Cell Receptors and Tumor Membrane Hsp70-Derived Peptide: A Combined Computational and Experimental Study. | Adv Sci (Weinh) | 2024 | 38298098 | PubTator, text mining | PubMed |
| Characterization of T cell receptor repertoire in penile cancer. | Cancer Immunol Immunother | 2024 | 38280010 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3822/papers?page=8